Dr. Jane Buckner Discusses Hydroxychloroquine T1D Prevention Study
Details about the TrialNet study, including why Hydroxychloroquine, and the status of subject participation.
At the Front Lines in COVID-19: Breakthrough T1D-Funded Scientist’s Company Developing a Vaccine
With coronavirus closing schools and forcing so many people to stay inside or wear facemasks every time they step outdoors,…
Zucara Faces “Valley of Death,” and Comes Out Triumphant
Low blood sugar, called hypoglycemia, is a real fear for people with type 1 diabetes (T1D). Although there are rescue…
Breakthrough T1D Awards World-Renowned T1D Researchers
Breakthrough T1D is honored to recognize five leading international researchers whose work has and is transforming type 1 diabetes (T1D)…
Universal Screening for Type 1 Diabetes: Its Time has Come?
Universal screening for type 1 diabetes (T1D) is a priority for Breakthrough T1D, but the cost versus benefits remain unclear.…
Can Prozac Prevent Severe Low Blood Sugar?
Low blood sugar, called hypoglycemia, occurs in over 90 percent of people with type 1 diabetes (T1D). It can usually…
The Promising Clinical Trials in the Breakthrough T1D Pipeline
As the leading global funder of type 1 diabetes (T1D) research, Breakthrough T1D invests in the most promising research studies…
One Less Device: Combining CGM and Insulin Infusion
Breakthrough T1D is funding work to build a better insulin infusion set; the current infusion sets can be uncomfortable and…
Why Does One Scientist Seek Cures for T1D? Answer: Family
Reza Abdi, M.D., has a reason to care about type 1 diabetes research—he has a father and a brother with…
Production of Insulin in People with Type 1 Diabetes
Sernova, a clinical-stage regenerative medicine company, has shown in its Breakthrough T1D-funded clinical trial that its cell replacement therapy, the…
